Support for Small Business Innovation Research (SBIR) to Development and Testing of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (R43/R44 Clinical Trial Not Allowed)

资助机构

HHS-NIH11(National Institutes of Health)

研究领域

Food and Nutrition

Health

截止日期

October 7, 2022 (已过期)

基金规模

$3,000,000

联系方式

National Institutes of Health grantsinfo@nih.gov

申请资格

Small businesses, Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

基金编号

RFA-DK-21-012

说明

This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications for funding to perform research leading to the development of novel and supportive technologies for the improvement of cell replacement interventions using novel methods, biomaterials and devices for type 1 diabetes (T1D) treatment.

网站

http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-21-012.html

基金资源
NIH General Instructions	下载文件
NIH Application Guide	打开链接
Purdue Grant Writing Lab: Introduction to Grant Writing	打开链接
University of Wisconsin Writing Center: Planning and Writing a Grant Proposal	打开链接